Kam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiPradėtinuo 449 $
Požymis
Fainting spell
Klinikinis pavadinimas: Syncope
A transient loss of consciousness (i.e., characterized by a rapid onset, a short duration, and a spontaneous and complete recovery) due to cerebral hypoperfusion.
Santrauka
Fainting spellHP:0001279
Kam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiPradėtinuo 449 $
Read the genes linked to Fainting spell, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test139 genų susiję su Fainting spell
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Fainting spell. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| AKAP9A-kinase anchoring protein 9 | Visada | 2 ligose |
| ARHGEF15Rho guanine nucleotide exchange factor 15 | Visada | 1 ligoje |
| CALM1calmodulin 1 | Visada | 1 ligoje |
| CASQ2calsequestrin 2 | Visada | 2 ligose |
| CTSAcathepsin A | Visada | 1 ligoje |
| GYS1glycogen synthase 1 | Visada | 2 ligose |
| HIVEP2HIVEP zinc finger 2 | Visada | 1 ligoje |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Visada | 4 ligose |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Visada | 7 ligose |
| LMNAlamin A/C | Visada | 2 ligose |
| NOTCH3notch receptor 3 | Visada | 1 ligoje |
| POPDC1popeye domain cAMP effector 1 | Visada | 1 ligoje |
| SNTA1syntrophin alpha 1 | Visada | 1 ligoje |
| CALM2calmodulin 2 | Labai dažnai (80–99%) | 1 ligoje |
| HCN4hyperpolarization activated cyclic nucleotide gated potassium channel 4 | Labai dažnai (80–99%) | 2 ligose |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Labai dažnai (80–99%) | 3 ligose |
| LAMP2lysosome associated membrane protein 2 | Labai dažnai (80–99%) | 2 ligose |
| NIT1nitrilase 1 | Labai dažnai (80–99%) | 1 ligoje |
| RYR2ryanodine receptor 2 | Labai dažnai (80–99%) | 1 ligoje |
| TRDNtriadin | Labai dažnai (80–99%) | 2 ligose |
| ABCC9ATP binding cassette subfamily C member 9 | Dažnai (30–79%) | 2 ligose |
| ALG10BALG10 alpha-1,2-glucosyltransferase B | Dažnai (30–79%) | 1 ligoje |
| CACNA1Ccalcium voltage-gated channel subunit alpha1 C | Dažnai (30–79%) | 3 ligose |
| CACNA1Dcalcium voltage-gated channel subunit alpha1 D | Dažnai (30–79%) | 1 ligoje |
| CACNA2D1calcium voltage-gated channel auxiliary subunit alpha2delta 1 | Dažnai (30–79%) | 2 ligose |
| CACNB2calcium voltage-gated channel auxiliary subunit beta 2 | Dažnai (30–79%) | 2 ligose |
| CAV3caveolin 3 | Dažnai (30–79%) | 1 ligoje |
| DBHdopamine beta-hydroxylase | Dažnai (30–79%) | 1 ligoje |
| DLSTdihydrolipoamide S-succinyltransferase | Dažnai (30–79%) | 1 ligoje |
| DNMT3ADNA methyltransferase 3 alpha | Dažnai (30–79%) | 1 ligoje |
| DSC2desmocollin 2 | Dažnai (30–79%) | 1 ligoje |
| ELNelastin | Dažnai (30–79%) | 1 ligoje |
| EPAS1endothelial PAS domain protein 1 | Dažnai (30–79%) | 1 ligoje |
| FHfumarate hydratase | Dažnai (30–79%) | 1 ligoje |
| GATA4GATA binding protein 4 | Dažnai (30–79%) | 2 ligose |
| GATA5GATA binding protein 5 | Dažnai (30–79%) | 1 ligoje |
| GATA6GATA binding protein 6 | Dažnai (30–79%) | 2 ligose |
| GJA5gap junction protein alpha 5 | Dažnai (30–79%) | 1 ligoje |
| GPD1Lglycerol-3-phosphate dehydrogenase 1 like | Dažnai (30–79%) | 2 ligose |
| JUPjunction plakoglobin | Dažnai (30–79%) | 2 ligose |
Rodyti dar 99 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| KCNA5potassium voltage-gated channel subfamily A member 5 | Dažnai (30–79%) | 1 ligoje |
| KCND3potassium voltage-gated channel subfamily D member 3 | Dažnai (30–79%) | 1 ligoje |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Dažnai (30–79%) | 2 ligose |
| KCNE3potassium voltage-gated channel subfamily E regulatory subunit 3 | Dažnai (30–79%) | 1 ligoje |
| KCNE5potassium voltage-gated channel subfamily E regulatory subunit 5 | Dažnai (30–79%) | 1 ligoje |
| KCNH2potassium voltage-gated channel subfamily H member 2 | Dažnai (30–79%) | 3 ligose |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Dažnai (30–79%) | 4 ligose |
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Dažnai (30–79%) | 1 ligoje |
| KCNJ8potassium inwardly rectifying channel subfamily J member 8 | Dažnai (30–79%) | 1 ligoje |
| KIF1Bkinesin family member 1B | Dažnai (30–79%) | 1 ligoje |
| MAXMYC associated transcriptional regulator X | Dažnai (30–79%) | 1 ligoje |
| MDH2malate dehydrogenase 2 | Dažnai (30–79%) | 1 ligoje |
| MYL4myosin light chain 4 | Dažnai (30–79%) | 1 ligoje |
| NF1neurofibromin 1 | Dažnai (30–79%) | 1 ligoje |
| NKX2-5NK2 homeobox 5 | Dažnai (30–79%) | 3 ligose |
| NKX2-6NK2 homeobox 6 | Dažnai (30–79%) | 1 ligoje |
| NPPAnatriuretic peptide A | Dažnai (30–79%) | 2 ligose |
| NUP155nucleoporin 155 | Dažnai (30–79%) | 1 ligoje |
| PITX2paired like homeodomain 2 | Dažnai (30–79%) | 1 ligoje |
| PKP2plakophilin 2 | Dažnai (30–79%) | 2 ligose |
| PRKAG2protein kinase AMP-activated non-catalytic subunit gamma 2 | Dažnai (30–79%) | 2 ligose |
| PSEN1presenilin 1 | Dažnai (30–79%) | 1 ligoje |
| RANGRFRAN guanine nucleotide release factor | Dažnai (30–79%) | 1 ligoje |
| RETret proto-oncogene | Dažnai (30–79%) | 2 ligose |
| SCN10Asodium voltage-gated channel alpha subunit 10 | Dažnai (30–79%) | 1 ligoje |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Dažnai (30–79%) | 3 ligose |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Dažnai (30–79%) | 2 ligose |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Dažnai (30–79%) | 2 ligose |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Dažnai (30–79%) | 1 ligoje |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Dažnai (30–79%) | 9 ligose |
| SCNN1Asodium channel epithelial 1 subunit alpha | Dažnai (30–79%) | 1 ligoje |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Dažnai (30–79%) | 1 ligoje |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Dažnai (30–79%) | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Dažnai (30–79%) | 2 ligose |
| SDHCsuccinate dehydrogenase complex subunit C | Dažnai (30–79%) | 1 ligoje |
| SDHDsuccinate dehydrogenase complex subunit D | Dažnai (30–79%) | 2 ligose |
| SEMA3Asemaphorin 3A | Dažnai (30–79%) | 1 ligoje |
| SLC25A11solute carrier family 25 member 11 | Dažnai (30–79%) | 1 ligoje |
| SLMAPsarcolemma associated protein | Dažnai (30–79%) | 1 ligoje |
| TECRLtrans-2,3-enoyl-CoA reductase like | Dažnai (30–79%) | 1 ligoje |
| TMEM127transmembrane protein 127 | Dažnai (30–79%) | 1 ligoje |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Dažnai (30–79%) | 3 ligose |
| TTNtitin | Dažnai (30–79%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Dažnai (30–79%) | 2 ligose |
| ABCC8ATP binding cassette subfamily C member 8 | Kartais (5–29%) | 1 ligoje |
| ACTC1actin alpha cardiac muscle 1 | Kartais (5–29%) | 2 ligose |
| ANK2ankyrin 2 | Kartais (5–29%) | 1 ligoje |
| ASXL1ASXL transcriptional regulator 1 | Kartais (5–29%) | 1 ligoje |
| CTSHcathepsin H | Kartais (5–29%) | 1 ligoje |
| DSPdesmoplakin | Kartais (5–29%) | 1 ligoje |
| GNB2G protein subunit beta 2 | Kartais (5–29%) | 1 ligoje |
| HCRThypocretin neuropeptide precursor | Kartais (5–29%) | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Kartais (5–29%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Kartais (5–29%) | 1 ligoje |
| HNF1AHNF1 homeobox A | Kartais (5–29%) | 1 ligoje |
| JAK2Janus kinase 2 | Kartais (5–29%) | 1 ligoje |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Kartais (5–29%) | 1 ligoje |
| KITKIT proto-oncogene, receptor tyrosine kinase | Kartais (5–29%) | 1 ligoje |
| MOGmyelin oligodendrocyte glycoprotein | Kartais (5–29%) | 1 ligoje |
| MPLMPL proto-oncogene, thrombopoietin receptor | Kartais (5–29%) | 1 ligoje |
| MYBPC3myosin binding protein C3 | Kartais (5–29%) | 2 ligose |
| MYOZ2myozenin 2 | Kartais (5–29%) | 1 ligoje |
| NOTCH2NLCnotch 2 N-terminal like C | Kartais (5–29%) | 1 ligoje |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Kartais (5–29%) | 1 ligoje |
| P2RY11purinergic receptor P2Y11 | Kartais (5–29%) | 1 ligoje |
| PSEN2presenilin 2 | Kartais (5–29%) | 1 ligoje |
| RNF125ring finger protein 125 | Kartais (5–29%) | 1 ligoje |
| SLC4A3solute carrier family 4 member 3 | Kartais (5–29%) | 2 ligose |
| SLC6A5solute carrier family 6 member 5 | Kartais (5–29%) | 1 ligoje |
| SRSF2serine and arginine rich splicing factor 2 | Kartais (5–29%) | 1 ligoje |
| TET2tet methylcytosine dioxygenase 2 | Kartais (5–29%) | 1 ligoje |
| THPOthrombopoietin | Kartais (5–29%) | 1 ligoje |
| TLL1tolloid like 1 | Kartais (5–29%) | 2 ligose |
| TNFSF4TNF superfamily member 4 | Kartais (5–29%) | 1 ligoje |
| TNNC1troponin C1, slow skeletal and cardiac type | Kartais (5–29%) | 1 ligoje |
| TRIM63tripartite motif containing 63 | Kartais (5–29%) | 1 ligoje |
| UCP2uncoupling protein 2 | Kartais (5–29%) | 1 ligoje |
| ZNF365zinc finger protein 365 | Kartais (5–29%) | 1 ligoje |
| AKT1AKT serine/threonine kinase 1 | Retai (1–4 %) | 1 ligoje |
| BAP1BRCA1 associated deubiquitinase 1 | Retai (1–4 %) | 1 ligoje |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Retai (1–4 %) | 1 ligoje |
| CLCNKBchloride voltage-gated channel Kb | Retai (1–4 %) | 1 ligoje |
| FLNCfilamin C | Retai (1–4 %) | 1 ligoje |
| KIF20Akinesin family member 20A | Retai (1–4 %) | 1 ligoje |
| MYH6myosin heavy chain 6 | Retai (1–4 %) | 1 ligoje |
| MYPNmyopalladin | Retai (1–4 %) | 1 ligoje |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Retai (1–4 %) | 1 ligoje |
| PDGFBplatelet derived growth factor subunit B | Retai (1–4 %) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Retai (1–4 %) | 1 ligoje |
| SLC12A3solute carrier family 12 member 3 | Retai (1–4 %) | 1 ligoje |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Retai (1–4 %) | 1 ligoje |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Retai (1–4 %) | 1 ligoje |
| SMOsmoothened, frizzled class receptor | Retai (1–4 %) | 1 ligoje |
| SUFUSUFU negative regulator of hedgehog signaling | Retai (1–4 %) | 1 ligoje |
| TBX20T-box transcription factor 20 | Retai (1–4 %) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Retai (1–4 %) | 1 ligoje |
| TNNI3troponin I3, cardiac type | Retai (1–4 %) | 1 ligoje |
| TNNT2troponin T2, cardiac type | Retai (1–4 %) | 1 ligoje |
| TRAF7TNF receptor associated factor 7 | Retai (1–4 %) | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Kam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiPradėtinuo 449 $
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites